ArticleInvestigational new drugs2021

Efficacy and safety of TAS-115, a novel oral multi-kinase inhibitor, in osteosarcoma: an expansion cohort of a phase I study.

Akira Kawai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.